BeyondSpring Inc. Noncontrolling Interest, Increase from Subsidiary Equity Issuance
BeyondSpring Inc. (BYSI) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $280.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2026-08-14
- BeyondSpring Inc. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2026-03-31 was $280.00K.
- BeyondSpring Inc. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2025-09-30 was $2.72M, a 86.40% decline year-over-year.
- BeyondSpring Inc. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2024-09-30 was $20.00M.
- BeyondSpring Inc. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2019-12-31 was $0.00.
- BeyondSpring Inc. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2025 was $2.72M, a 86.40% decline from fiscal 2024.
- BeyondSpring Inc. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2024 was $20.00M.
| Period end | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 3 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 9 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month |
|---|---|---|---|
| 2026-03-31 | $280.00K 10-Q · filed 2026-08-14 | ||
| 2025-12-31 | $2.72M 10-K · filed 2026-03-25 | ||
| 2025-09-30 | $2.72M 10-Q · filed 2025-11-12 | ||
| 2024-12-31 | $20.00M 10-K · filed 2026-03-25 | ||
| 2024-09-30 | $20.00M 10-Q · filed 2025-11-12 | ||
| 2020-12-31 | $80.00K 20-F · filed 2023-04-18 | ||
| 2019-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | $10.08M 20-F · filed 2022-04-14 | |
| 2019-09-30 | $10.08M 6-K · filed 2020-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |